Artificial intelligence-based personalized clinical decision-making for patients with localized prostate cancer: surgery versus radiotherapy.

Journal: The oncologist
Published Date: Dec 6, 2024

Abstract

BACKGROUND: Surgery and radiotherapy are primary nonconservative treatments for prostate cancer (PCa). However, personalizing treatment options between these treatment modalities is challenging due to unclear criteria. We developed an artificial intelligence (AI)-based model that can identify patients with localized PCa who would benefit more from either radiotherapy or surgery, thereby providing personalized clinical decision-making.

Authors

  • Yuwei Liu
    Department of Electrical and Computer Engineering, New Jersey Institute of Technology, University Heights, Newark, NJ 07102, USA.
  • Litao Zhao
    School of Engineering Medicine, Beihang University, Beijing, 100191, China.
  • Jiangang Liu
    School of Computer and Information Technology, Beijing Jiaotong University, Beijing, 100044, China.
  • Liang Wang
    Information Department, Dazhou Central Hospital, Dazhou 635000, China.

Keywords

External Resources

Popular Topics
Recent Journals